CINA-ICH

Avicenna.AI
The CINA-ICH solution provides automated detection and prioritization of acute intracerebral hemorrhage on non-contrast CT (NCCT).
avicenna-cina-ich.PNG
Information source: Vendor
Last updated: September 4, 2024

General Information

General
Product name CINA-ICH
Company Avicenna.AI
Subspeciality Neuro
Modality CT
Disease targeted Intracranial Hemorrhage, Stroke, Trauma
Key-features Intracranial Hemorrhage detection, notification
Suggested use Before: adapting worklist order, flagging acute findings

Technical Specifications

Data characteristics
Population Suspicion of stroke, Suspicion of head trauma
Input Non contrast CT
Input format DICOM
Output segmentation contour, worklist order, notification
Output format DICOM SC, GSPS
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition
Processing time 10 - 60 seconds

Regulatory

Certification
CE
Certified, Class IIb , MDR
FDA 510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE) CINA is a radiological computer aided triage and notification software indicated for use in the analysis of (1) non-enhanced head CT images and (2) CT angiographies of the head. The device is intended to assist hospital networks and trained radiologists in workflow triage by flagging and communicating suspected positive findings of (1) head CT images for Intracranial Hemorrhage (ICH) and (2) CT angiographies of the head for large vessel occlusion (LVO). CINA uses an artificial intelligence algorithm to analyze images and highlight cases with detected (1) ICH or (2) LVO on a standalone Web application in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected ICH or LVO findings. Notifications include compressed preview images that are meant for informational purposes only, and are not intended for diagnostic use beyond notification. The device does not alter the original medical image, and it is not intended to be used as a diagnostic device. The results of CINA are intended to be used in conjunction with other patient information and based on professional judgment to assist with triage/prioritization of medical images. Notified clinicians are ultimately responsible for reviewing full images per the standard of care.

Market

Market presence
On market since 02-2020
Distribution channels Eureka Clinical AI, Canon Automation Platform, Blackford, Tempus Pixel, Nuance PIN, Sectra Amplifier Store, deepcOS, Incepto, CARPL.ai, Calantic
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use, Subscription
Based on Number of installations, Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
  • Deep Learning to Detect Intracranial Hemorrhage in a National Teleradiology Program and the Impact on Interpretation Time (read)


  • Assessment of an Artificial Intelligence Algorithm for Detection of Intracranial Hemorrhage (read)

  • Validation of a Deep Learning Tool in the Detection of Intracranial Hemorrhage and Large Vessel Occlusion (read)
Non-peer reviewed papers on performance
Other relevant papers